{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:43:25Z","timestamp":1775673805933,"version":"3.50.1"},"reference-count":261,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Classical psychedelics represent a family of psychoactive substances with structural similarities to serotonin and affinity for serotonin receptors. A growing number of studies have found that psychedelics can be effective in treating various psychiatric conditions, including post-traumatic stress disorder, major depressive disorder, anxiety, and substance use disorders. Mental health disorders are extremely prevalent in the general population constituting a major problem for the public health. There are a wide variety of interventions for mental health disorders, including pharmacological therapies and psychotherapies, however, treatment resistance still remains a particular challenge in this field, and relapse rates are also quite high. In recent years, psychedelics have become one of the promising new tools for the treatment of mental health disorders. In this review, we will discuss the three classic serotonergic naturally occurring psychedelics, psilocybin, ibogaine, and N, N-dimethyltryptamine, focusing on their pharmacological properties and clinical potential. The purpose of this article is to provide a focused review of the most relevant research into the therapeutic potential of these substances and their possible integration as alternative or adjuvant options to existing pharmacological and psychological therapies.<\/jats:p>","DOI":"10.3389\/fphar.2022.927984","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T06:52:40Z","timestamp":1656399160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Nataliya","family":"Vorobyeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena A.","family":"Kozlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12024-020-00342-0","article-title":"Death Due to Consumption of Ibogaine: Case Report","volume":"17","author":"A\u0107imovi\u0107","year":"2021","journal-title":"Forensic Sci. Med. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16S","DOI":"10.1016\/S0893-133X(98)00135-3","article-title":"Serotonin and Hallucinogens","volume":"21","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term Follow-Up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Life-Threatening Cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00213-008-1316-3","article-title":"Responses of Limbic and Extrapyramidal Substance P Systems to Nicotine Treatment","volume":"201","author":"Alburges","year":"2009","journal-title":"Psychopharmacol. Berl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0169-328x(99)00283-1","article-title":"Acute Ibogaine Injection Induces Expression of the Immediate Early Genes, Egr-1 and C-Fos, in Mouse Brain","volume":"74","author":"Ali","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0099-9598(01)56018-6","article-title":"A Contemporary History of Ibogaine in the United States and Europe","volume":"56","author":"Alper","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Ibogaine: a Review","volume":"56","author":"Alper","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","article-title":"Fatalities Temporally Associated with the Ingestion of Ibogaine","volume":"57","author":"Alper","year":"2012","journal-title":"J. Forensic Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/0973-1229.58825","article-title":"Stahl\u2032s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","volume":"8","author":"Andrade","year":"2010","journal-title":"Mens. Sana Monogr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e77262","DOI":"10.1371\/journal.pone.0077262","article-title":"Effect of Iboga Alkaloids on \u039c-Opioid Receptor-Coupled G Protein Activation","volume":"8","author":"Antonio","year":"2013","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.biocel.2010.05.011","article-title":"Interaction of Ibogaine with Human Alpha3beta4-Nicotinic Acetylcholine Receptors in Different Conformational States","volume":"42","author":"Arias","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1755-7682-3-24","article-title":"Dopaminergic Reward System: a Short Integrative Review","volume":"3","author":"Arias-Carri\u00f3n","year":"2010","journal-title":"Int. Arch. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00418-013-1081-1","article-title":"Serotonergic Innervation of the Amygdala: Targets, Receptors, and Implications for Stress and Anxiety","volume":"139","author":"Asan","year":"2013","journal-title":"Histochem Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","article-title":"Pharmacochaperoning in a Drosophila Model System Rescues Human Dopamine Transporter Variants Associated with Infantile\/juvenile Parkinsonism","volume":"292","author":"Asjad","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","article-title":"A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Na\u00efve Subjects","volume":"41","author":"Barbosa","year":"2009","journal-title":"J. Psychoact. Drugs"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1002\/9781118105955","volume-title":"Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants","author":"Barceloux","year":"2012"},{"key":"B17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine its Role and Function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"116980","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin Acutely Alters the Functional Connectivity of the Claustrum with Brain Networks that Support Perception, Memory, and Attention","volume":"218","author":"Barrett","year":"2020","journal-title":"NeuroImage"},{"key":"B19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/dev.20546","article-title":"BDNF Control of Adult SVZ Neurogenesis","volume":"54","author":"Bath","year":"2012","journal-title":"Dev. Psychobiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical Hallucinogens as Antidepressants? A Review of Pharmacodynamics and Putative Clinical Roles","volume":"4","author":"Baumeister","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/PRA.0000000000000409","article-title":"Hallucinogens and Their Therapeutic Use: A Literature Review","volume":"25","author":"Begola","year":"2019","journal-title":"J. Psychiatr. Pract."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine 2A Receptor-Mediated Facilitation of Synaptic Activity in Prefrontal Cortex","volume":"104","author":"B\u00e9\u00efque","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e826","DOI":"10.1038\/tp.2016.71","article-title":"Ibogaine and Addiction in the Animal Model, a Systematic Review and Meta-Analysis","volume":"6","author":"Belgers","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamapediatrics.2015.4263","article-title":"The Differential Susceptibility Hypothesis: Sensitivity to the Environment for Better and for Worse","volume":"170","author":"Belsky","year":"2016","journal-title":"JAMA Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molmed.2017.12.004","article-title":"Focusing on the Opioid System for Addiction Biomarker Discovery","volume":"24","author":"Belzeaux","year":"2018","journal-title":"Trends Mol. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1476-5381.1996.tb15253.x","article-title":"Neurochemical and Behavioural Interactions between Ibogaine and Nicotine in the Rat","volume":"117","author":"Benwell","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s0006-8993(96)01461-8","article-title":"Effects of Ibogaine and Noribogaine on the Antinociceptive Action of Mu-, Delta- and Kappa-Opioid Receptor Agonists in Mice","volume":"752","author":"Bhargava","year":"1997","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted Treatment for Alcohol Dependence: A Proof-Of-Concept Study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic Hallucinogens in the Treatment of Addictions","volume":"64","author":"Bogenschutz","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, Psychopathology, Life Attitudes and Neuropsychological Performance Among Ritual Users of Ayahuasca: A Longitudinal Study","volume":"7","author":"Bouso","year":"2012","journal-title":"PLOS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0031-6865(99)00034-5","article-title":"Sigma Receptors: Recent Advances and New Clinical Potentials","volume":"74","author":"Bowen","year":"2000","journal-title":"Pharm. Acta Helv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s40262-017-0540-6","article-title":"Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults","volume":"56","author":"Brown","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the Treatment of Substance Dependence","volume":"6","author":"Brown","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fnins.2015.00413","article-title":"Role of Central Vagal 5-HT3 Receptors in Gastrointestinal Physiology and Pathophysiology","volume":"9","author":"Browning","year":"2015","journal-title":"Front. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","article-title":"The Mysterious Trace Amines: Protean Neuromodulators of Synaptic Transmission in Mammalian Brain","volume":"79","author":"Burchett","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the Prototype Glutamatergic Antidepressant: Pharmacodynamic Actions, and a Systematic Review and Meta-Analysis of Efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0378-8741(98)00168-8","article-title":"Pharmacokinetics of Hoasca Alkaloids in Healthy Humans","volume":"65","author":"Callaway","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","article-title":"Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT)","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A Non-hallucinogenic Psychedelic Analogue with Therapeutic Potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s0006-8993(96)01470-9","article-title":"Effects of Ibogaine on the Development of Tolerance to Antinociceptive Action of Mu-, Delta- and Kappa-Opioid Receptor Agonists in Mice","volume":"752","author":"Cao","year":"1997","journal-title":"Brain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey Study of Challenging Experiences after Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-Dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"B44","article-title":"Hallucinogens","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"Carey","year":"2015"},{"key":"B45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacol. Berl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with Psychological Support for Treatment-Resistant Depression: an Open-Label Feasibility Study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of Psilocybin on Hippocampal Neurogenesis and Extinction of Trace Fear Conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp. Brain Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0028-3908(96)84107-4","article-title":"Ibogaine Block of the NMDA Receptor: In Vitro and In Vivo Studies","volume":"35","author":"Chen","year":"1996","journal-title":"Neuropharmacology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13041-020-00601-9","article-title":"Arginine Is Neuroprotective through Suppressing HIF-1\u03b1\/ldha-Mediated Inflammatory Response after Cerebral Ischemia\/reperfusion Injury","volume":"13","author":"Chen","year":"2020","journal-title":"Mol. Brain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S2215-0366(16)30024-4","article-title":"Scaling-up Treatment of Depression and Anxiety: a Global Return on Investment Analysis","volume":"3","author":"Chisholm","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/02791072.2016.1180467","article-title":"Remission of Severe Opioid Use Disorder with Ibogaine: a Case Report","volume":"48","author":"Cloutier-Gill","year":"2016","journal-title":"J. Psychoact. Drugs"},{"key":"B54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"PL315","DOI":"10.1016\/0024-3205(95)02171-e","article-title":"High Affinity Ibogaine Binding to a Mu Opioid Agonist Site","volume":"57","author":"Codd","year":"1995","journal-title":"Life Sci."},{"key":"B56","first-page":"175","article-title":"Chapter 4 Hallucinogens","volume-title":"Handbook of Analytical Separations. Forensic Science","author":"Cody","year":"2008"},{"key":"B57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","article-title":"Serotonin Transporter-Ibogaine Complexes Illuminate Mechanisms of Inhibition and Transport","volume":"569","author":"Coleman","year":"2019","journal-title":"Nature"},{"key":"B58","unstructured":"Psilocybin Therapy and Treatment | Magic Mushroom Therapy2021"},{"key":"B59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1152\/jn.00109.2007","article-title":"Reduced 5-HT1A- and GABAB Receptor Function in Dorsal Raph\u00e9 Neurons upon Chronic Fluoxetine Treatment of Socially Stressed Rats","volume":"98","author":"Cornelisse","year":"2007","journal-title":"J. Neurophysiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/wps.20229","article-title":"What Has Serotonin to Do with Depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and Other Hallucinogenic Tryptamines Exhibit Substrate Behavior at the Serotonin Uptake Transporter and the Vesicle Monoamine Transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0014-2999(00)00308-3","article-title":"Desensitisation of 5-HT Autoreceptors upon Pharmacokinetically Monitored Chronic Treatment with Citalopram","volume":"397","author":"Cremers","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.bjp.0705762","article-title":"Role of Serotonin in the Pathophysiology of the Irritable Bowel Syndrome","volume":"141","author":"Crowell","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3390\/molecules26092451","article-title":"Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans","volume":"26","author":"Cumming","year":"2021","journal-title":"Molecules"},{"key":"B65","volume-title":"Novel Psychoactive Substances: Classification, Pharmacology and Toxicology","author":"Dargan","year":"2013"},{"key":"B66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1556\/2054.01.2017.009","article-title":"Subjective Effectiveness of Ibogaine Treatment for Problematic Opioid Consumption: Short- and Long-Term Outcomes and Current Psychological Functioning","volume":"1","author":"Davis","year":"2017","journal-title":"J. Psychedelic Stud."},{"key":"B67","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J. Neurosci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14737175.2016.1220834","article-title":"Psilocybin for Treating Substance Use Disorders?","volume":"17","author":"de Veen","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-3806(90)90065-7","article-title":"Ontogeny of \u03bc-, \u03b4- and \u03ba-opioid Receptors Mediating Inhibition of Neurotransmitter Release and Adenylate Cyclase Activity in Rat Brain","volume":"54","author":"De Vries","year":"1990","journal-title":"Dev. Brain Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain","volume":"9","author":"Dean","year":"2019","journal-title":"Sci. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0006-8993(92)90661-r","article-title":"Mechanisms of Action of Ibogaine and Harmaline Congeners Based on Radioligand Binding Studies","volume":"571","author":"Deecher","year":"1992","journal-title":"Brain Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do Benzodiazepines Still Deserve a Major Role in the Treatment of Psychiatric Disorders? A Critical Reappraisal","volume":"28","author":"Dell\u2019osso","year":"2013","journal-title":"Eur. Psychiatr."},{"key":"B73","unstructured":"US2813873A1957"},{"key":"B74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","article-title":"Metabolism of Psilocybin and Psilocin: Clinical and Forensic Toxicological Relevance","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","article-title":"Efficacy, Tolerability, and Safety of Serotonergic Psychedelics for the Management of Mood, Anxiety, and Substance-Use Disorders: a Systematic Review of Systematic Reviews","volume":"11","author":"Dos Santos","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/2045125316689030","article-title":"Ayahuasca, Dimethyltryptamine, and Psychosis: a Systematic Review of Human Studies","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of Ayahuasca Administered in Two Repeated Doses","volume":"219","author":"Dos Santos","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"B78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, Anxiolytic, and Antiaddictive Effects of Ayahuasca, Psilocybin and Lysergic Acid Diethylamide (LSD): a Systematic Review of Clinical Trials Published in the Last 25 Years","volume":"6","author":"Dos Santos","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","article-title":"Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca: a Comparative Study with D-Amphetamine","volume":"31","author":"Dos Santos","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF02246099","article-title":"Effects of Ibogaine on Responding Maintained by Food, Cocaine and Heroin Reinforcement in Rats","volume":"117","author":"Dworkin","year":"1995","journal-title":"Psychopharmacol. Berl."},{"key":"B82","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jep.2005.04.022","article-title":"Prehistoric Peyote Use: Alkaloid Analysis and Radiocarbon Dating of Archaeological Specimens of Lophophora from Texas","volume":"101","author":"El-Seedi","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/acps.12904","article-title":"Effects of Psilocybin Therapy on Personality Structure","volume":"138","author":"Erritzoe","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"B84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of Addiction Severity Among Ritual Users of Ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug Alcohol Dependence"},{"key":"B85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13011-020-0256-8","article-title":"The Opioid Mortality Epidemic in North America: Do We Understand the Supply Side Dynamics of This Unprecedented Crisis?","volume":"15","author":"Fischer","year":"2020","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The Hallucinogen N,N-dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/da.20208","article-title":"Functional Neuroimaging Studies in Posttraumatic Stress Disorder: Review of Current Methods and Findings","volume":"24","author":"Francati","year":"2007","journal-title":"Depress Anxiety"},{"key":"B88","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1472-8206.1992.tb00127.x","article-title":"Effects of Ibogaine on Naloxone-Precipitated Withdrawal in Morphine-dependent Mice","volume":"6","author":"Franc\u00e9s","year":"1992","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed Pharmacological Effects of Antidepressants","author":"Frazer","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","article-title":"A Possibly Sigma-1 Receptor Mediated Role of Dimethyltryptamine in Tissue Protection, Regeneration, and Immunity","volume":"120","author":"Frecska","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/syn.21549","article-title":"Sigma-1 Receptor Chaperones Regulate the Secretion of Brain-Derived Neurotrophic Factor","volume":"66","author":"Fujimoto","year":"2012","journal-title":"Synapse"},{"key":"B92","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ALN.0000000000000434","article-title":"Brain Serotonin Content Regulates the Manifestation of Tramadol-Induced Seizures in Rats: Disparity between Tramadol-Induced Seizure and Serotonin Syndrome","volume":"122","author":"Fujimoto","year":"2015","journal-title":"Anesthesiology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","article-title":"Comparison of Acute Lethal Toxicity of Commonly Abused Psychoactive Substances","volume":"99","author":"Gable","year":"2004","journal-title":"Addiction"},{"key":"B94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","article-title":"Risk Assessment of Ritual Use of Oral Dimethyltryptamine (DMT) and Harmala Alkaloids","volume":"102","author":"Gable","year":"2007","journal-title":"Addiction"},{"key":"B95","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fpsyt.2018.00185","article-title":"Cortisol Modulation by Ayahuasca in Patients with Treatment Resistant Depression and Healthy Controls","volume":"9","author":"Galv\u00e3o","year":"2018","journal-title":"Front. Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"5-HT(1A) [corrected] Receptors in Mood and Anxiety: Recent Insights into Autoreceptor versus Heteroreceptor Function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacol. Berl."},{"key":"B97","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned Mystical Experiences in the Treatment of Tobacco Addiction","volume":"7","author":"Garcia-Romeu","year":"2015","journal-title":"Curr. Drug Abuse Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4088\/JCP.8133su1c.02","article-title":"Identifying Difficult-To-Treat Depression: Differential Diagnosis, Subtypes, and Comorbidities","author":"Gaynes","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"B99","first-page":"31","article-title":"A Psycho-Pharmacological Study of Some Indole Alkaloids","volume":"135","author":"Gershon","year":"1962","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neubiorev.2009.11.009","article-title":"Role of BDNF and GDNF in Drug Reward and Relapse: a Review","volume":"35","author":"Ghitza","year":"2010","journal-title":"Neurosci. Biobehav Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 Involvement in the Mechanism of Action of Hallucinogenic Agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0006-8993(94)90948-2","article-title":"Effects of Iboga Alkaloids on Morphine and Cocaine Self-Administration in Rats: Relationship to Tremorigenic Effects and to Effects on Dopamine Release in Nucleus Accumbens and Striatum","volume":"657","author":"Glick","year":"1994","journal-title":"Brain Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0014-2999(91)90474-5","article-title":"Effects and Aftereffects of Ibogaine on Morphine Self-Administration in Rats","volume":"195","author":"Glick","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jcph.404","article-title":"Ascending-dose Study of Noribogaine in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability","volume":"55","author":"Glue","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"B106","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic Effects of Psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and D-Methamphetamine in Healthy Volunteers. A Double-Blind, Placebo-Controlled PET Study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer: A Randomized Double-Blind Trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned Mystical-type Experience in Combination with Meditation and Other Spiritual Practices Produces Enduring Positive Changes in Psychological Functioning and in Trait Measures of Prosocial Attitudes and Behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin Occasioned Mystical-type Experiences: Immediate and Persisting Dose-Related Effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"B110","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/scientificamerican1210-76","article-title":"Hallucinogens as Medicine","volume":"303","author":"Griffths","year":"2010","journal-title":"Sci. Am."},{"key":"B111","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-Stage Cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"B112","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/08037050310015458","article-title":"Effectiveness of Hypertension Treatment Assessed by Blood Pressure Level Achieved in Primary Care Setting in Poland","volume":"12","author":"Grzybowski","year":"2003","journal-title":"Blood Press"},{"key":"B113","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting Responses to Psychedelics: A Prospective Study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple Receptors Contribute to the Behavioral Effects of Indoleamine Hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2004.03.003","article-title":"Hallucinogens and Dissociative Agents Naturally Growing in the United States","volume":"102","author":"Halpern","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"B116","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1570159X16666180125095902","article-title":"Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness","volume":"17","author":"Hamill","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"20120407","DOI":"10.1098\/rstb.2012.0407","article-title":"'It's the Way that You Look at It'-Aa Cognitive Neuropsychological Account of SSRI Action in Depression","volume":"368","author":"Harmer","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and Setting, Psychedelics and the Placebo Response: An Extra-pharmacological Perspective on Psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"205032451668332","DOI":"10.1177\/2050324516683325","article-title":"Constructing Drug Effects: A History of Set and Setting","volume":"3","author":"Hartogsohn","year":"2017","journal-title":"Drug Sci. Policy Law"},{"key":"B120","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0031-6865(97)00014-9","article-title":"Determination of Psilocin and 4-Hydroxyindole-3-Acetic Acid in Plasma by HPLC-ECD and Pharmacokinetic Profiles of Oral and Intravenous Psilocybin in Man","volume":"72","author":"Hasler","year":"1997","journal-title":"Pharm. Acta Helv."},{"key":"B121","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0731-7085(02)00278-9","article-title":"Renal Excretion Profiles of Psilocin Following Oral Administration of Psilocybin: a Controlled Study in Man","volume":"30","author":"Hasler","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B122","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute Psychological and Physiological Effects of Psilocybin in Healthy Humans: a Double-Blind, Placebo-Controlled Dose-Effect Study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"B123","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/157015905774322516","article-title":"The Sigma Receptor: Evolution of the Concept in Neuropsychopharmacology","volume":"3","author":"Hayashi","year":"2005","journal-title":"Curr. Neuropharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s0006-8993(97)00365-x","article-title":"Effects of Chronic Ibogaine Treatment on Cerebellar Purkinje Cells in the Rat","volume":"759","author":"Helsley","year":"1997","journal-title":"Brain Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0278-5846(98)00031-1","article-title":"A Comparison of N,N-dimethyltryptamine, Harmaline, and Selected Congeners in Rats Trained with LSD as a Discriminative Stimulus","volume":"22","author":"Helsley","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B126","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic Psychedelic Use Is Associated with Reduced Psychological Distress and Suicidality in the United States Adult Population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hlca.19590420518","article-title":"Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen","volume":"42","author":"Hofmann","year":"1959","journal-title":"Helv. Chim. Acta"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.711255","article-title":"Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin","volume":"12","author":"Holze","year":"2021","journal-title":"Fron. Pharm."},{"key":"B129","doi-asserted-by":"publisher","first-page":"PL119","DOI":"10.1016\/0024-3205(95)02322-4","article-title":"Tissue Distribution of Ibogaine after Intraperitoneal and Subcutaneous Administration","volume":"58","author":"Hough","year":"1996","journal-title":"Life Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.mehy.2004.11.005","article-title":"Endogenous Psychoactive Tryptamines Reconsidered: an Anxiolytic Role for Dimethyltryptamine","volume":"64","author":"Jacob","year":"2005","journal-title":"Med. Hypotheses"},{"key":"B131","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5941\/MYCO.2014.42.3.215","article-title":"Toxicological Profiles of Poisonous, Edible, and Medicinal Mushrooms","volume":"42","author":"Jo","year":"2014","journal-title":"Mycobiology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics Not Linked to Mental Health Problems or Suicidal Behavior: a Population Study","volume":"29","author":"Johansen","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human Hallucinogen Research: Guidelines for Safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential Therapeutic Effects of Psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B135","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The Abuse Potential of Medical Psilocybin According to the 8 Factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jchromb.2003.08.030","article-title":"Optimized Glucuronide Hydrolysis for the Detection of Psilocin in Human Urine Samples","volume":"796","author":"Kamata","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11419-009-0087-9","article-title":"Metabolism and Toxicological Analyses of Hallucinogenic Tryptamine Analogues Being Abused in Japan","volume":"28","author":"Kamata","year":"2010","journal-title":"Forensic Toxicol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/acsmedchemlett.0c00048","article-title":"Psilocybin Therapeutic Research: The Present and Future Paradigm","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"B139","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00023210-200923020-00002","article-title":"Current Considerations in the Treatment of Generalized Anxiety Disorder","volume":"23","author":"Katzman","year":"2009","journal-title":"CNS Drugs"},{"key":"B140","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0091-3057(94)00367-r","article-title":"Effects of Ibogaine on Sensory-Motor Function, Activity, and Spatial Learning in Rats","volume":"51","author":"Kesner","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/molecules20022208","article-title":"The Anti-addiction Drug Ibogaine and the Heart: a Delicate Relation","volume":"20","author":"Koenig","year":"2015","journal-title":"Molecules"},{"key":"B142","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1369-1600.2012.00447.x","article-title":"Anti-addiction Drug Ibogaine Inhibits hERG Channels: a Cardiac Arrhythmia Risk","volume":"19","author":"Koenig","year":"2014","journal-title":"Addict. Biol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced Spiritual Experiences and Insightfulness Are Associated with Synchronization of Neuronal Oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacol. Berl."},{"key":"B144","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State toward Positive Relative to Negative Emotions through Different Serotonergic Subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B145","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on \u03b1 Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J. Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B147","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The Molecular Neurobiology of Depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.5897\/JMPR11.1750","article-title":"Cumulation of Tabernanthe Iboga Alkaloid and its Metabolite in Organs of Mice","volume":"6","author":"Kubilien\u0117","year":"2012","journal-title":"J. Med. Plants Res."},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-40426-9","author":"Labate","year":"2014","journal-title":"The Therapeutic Use of Ayahuasca"},{"key":"B149","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00176767","article-title":"Early Desensitization of Somato-Dendritic 5-HT1A Autoreceptors in Rats Treated with Fluoxetine or Paroxetine","volume":"352","author":"Le Poul","year":"1995","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1021\/cn500340j","article-title":"Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine","volume":"6","author":"Leiser","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/02791072.2012.704590","article-title":"Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions","volume":"44","author":"Liester","year":"2012","journal-title":"J. Psychoact. Drugs"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1445-5994.2012.02955.x","article-title":"A Fatal Case of 'magic Mushroom' Ingestion in a Heart Transplant Recipient","volume":"42","author":"Lim","year":"2012","journal-title":"Intern Med. J."},{"key":"B153","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/15563650.2016.1138226","article-title":"How Toxic Is Ibogaine?","volume":"54","author":"Litjens","year":"2016","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.14814\/phy2.12873","article-title":"5-HT2B Receptor Antagonists Attenuate Myofibroblast Differentiation and Subsequent Fibrotic Responses In Vitro and In Vivo","volume":"4","author":"L\u00f6fdahl","year":"2016","journal-title":"Physiol. Rep."},{"key":"B155","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics Promote Structural and Functional Neural Plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"B156","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.mehy.2006.02.050","article-title":"Fatalities after Taking Ibogaine in Addiction Treatment Could Be Related to Sudden Cardiac Death Caused by Autonomic Dysfunction","volume":"67","author":"Maas","year":"2006","journal-title":"Med. Hypotheses"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness","volume":"25","author":"MacLean","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic Effects of Psilocybin Correlate with Serotonin 2A Receptor Occupancy and Plasma Psilocin Levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B159","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A Single Psilocybin Dose Is Associated with Long-Term Increased Mindfulness, Preceded by a Proportional Change in Neocortical 5-HT2A Receptor Binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0006-8993(98)00207-8","article-title":"Ibogaine Acts at the Nicotinic Acetylcholine Receptor to Inhibit Catecholamine Release","volume":"797","author":"Mah","year":"1998","journal-title":"Brain Res."},{"key":"B260","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.3390\/ijms21239279","article-title":"Toxicology and Analysis of Psychoactive Tryptamines","volume":"21","author":"Malaca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/newbio230085a0","article-title":"Indole(ethyl)amine N-Methyltransferase in Human Brain","volume":"230","author":"Mandell","year":"1971","journal-title":"Nat. New Biol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/dmd.109.031138","article-title":"Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases","volume":"38","author":"Manevski","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B163","first-page":"76","article-title":"Physiological Antagonism between 5-hydroxytryptamine(2A) and Group II Metabotropic Glutamate Receptors in Prefrontal Cortex","volume":"292","author":"Marek","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2019.00193","article-title":"Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits","volume":"10","author":"Marton","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fphar.2018.00529","article-title":"Ibogaine Detoxification Transitions Opioid and Cocaine Abusers between Dependence and Abstinence: Clinical Observations and Treatment Outcomes","volume":"9","author":"Mash","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1749-6632.1998.tb08242.x","article-title":"Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence","volume":"844","author":"Mash","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures","volume":"914","author":"Mash","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"CD002207","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine Maintenance versus Placebo or Methadone Maintenance for Opioid Dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B169","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","article-title":"Clinical Investigations of the Therapeutic Potential of Ayahuasca: Rationale and Regulatory Challenges","volume":"102","author":"McKenna","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"B170","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential Interactions of Indolealkylamines with 5-hydroxytryptamine Receptor Subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"key":"B171","first-page":"21","article-title":"The Healing Vine: Ayahuasca as Medicine in the 21st Century","volume-title":"Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments","author":"McKenna","year":"2007"},{"key":"B172","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine Oxidase Inhibitors in South American Hallucinogenic Plants: Tryptamine and Beta-Carboline Constituents of Ayahuasca","volume":"10","author":"McKenna","year":"1984","journal-title":"J. Ethnopharmacol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic Mechanisms of Psilocybin: Changes in Amygdala and Prefrontal Functional Connectivity during Emotional Processing after Psilocybin for Treatment-Resistant Depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/02791072.1998.10399709","article-title":"Hallucinogenic Drugs and Plants in Psychotherapy and Shamanism","volume":"30","author":"Metzner","year":"1998","journal-title":"J. Psychoact. Drugs"},{"key":"B175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/15733998113099990002","article-title":"Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin","volume":"6","author":"Michael","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"B176","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/14734220601016080","article-title":"Rodent Models of Tremor","volume":"6","author":"Miwa","year":"2007","journal-title":"Cerebellum"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients with Obsessive-Compulsive Disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"B178","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic Glutamate mGlu2 Receptor Is Necessary for the Pharmacological and Behavioral Effects Induced by Hallucinogenic 5-HT2A Receptor Agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1360-0443.1994.tb02787.x","article-title":"The Generalizability of the Dependence Syndrome across Substances: an Examination of Some Properties of the Proposed DSM-IV Dependence Criteria","volume":"89","author":"Morgenstern","year":"1994","journal-title":"Addiction"},{"key":"B180","first-page":"193","article-title":"Suicide under the Influence of \u2018magic Mushrooms\u2019","volume":"231","author":"M\u00fcller","year":"2013","journal-title":"Arch. Fur Kriminol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband Cortical Desynchronization Underlies the Human Psychedelic State","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"key":"B182","first-page":"427","article-title":"Effects of (+) SKF 10,047, a Sigma-1 Receptor Agonist, on Anxiety,tested in Two Laboratory Models in Mice","volume":"24","author":"Navarro","year":"2012","journal-title":"Psicothema"},{"key":"B183","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","article-title":"Anxiolytic-like Effects of 5-HT2 Ligands on Three Mouse Models of Anxiety","volume":"140","author":"Nic Dhonnchadha","year":"2003","journal-title":"Behav. Brain Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin Receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem. Rev."},{"key":"B185","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B186","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","article-title":"Ibogaine Treatment Outcomes for Opioid Dependence from a Twelve-Month Follow-Up Observational Study","volume":"44","author":"Noller","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B187","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of Diagnosis and Drug Treatments of Anxiety Disorders","volume":"10","author":"Nutt","year":"2005","journal-title":"CNS Spectr."},{"key":"B188","unstructured":"Post-traumatic Stress Disorder Treatment with Psychedelic Drugs2021"},{"key":"B189","first-page":"764","article-title":"Cytochrome P4502D6 Catalyzes the O-Demethylation of the Psychoactive Alkaloid Ibogaine to 12-Hydroxyibogamine","volume":"26","author":"Obach","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"B190","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0306-4522(93)90500-F","article-title":"Degeneration of Purkinje Cells in Parasagittal Zones of the Cerebellar Vermis after Treatment with Ibogaine or Harmaline","volume":"55","author":"O\u2019Hearn","year":"1993","journal-title":"Neuroscience"},{"key":"B191","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.physbeh.2015.01.032","article-title":"Effects of Ayahuasca on the Development of Ethanol-Induced Behavioral Sensitization and on a Post-sensitization Treatment in Mice","volume":"142","author":"Oliveira-Lima","year":"2015","journal-title":"Physiol. Behav."},{"key":"B192","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fpsyt.2017.00240","article-title":"The \"Endless Trip\" Among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review","volume":"8","author":"Orsolini","year":"2017","journal-title":"Front. Psychiatry"},{"key":"B193","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant Effects of a Single Dose of Ayahuasca in Patients with Recurrent Depression: a Preliminary Report","volume":"37","author":"Os\u00f3rio","year":"20151999","journal-title":"Rev. Bras. Psiquiatr."},{"key":"B194","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid Antidepressant Effects of the Psychedelic Ayahuasca in Treatment-Resistant Depression: a Randomized Placebo-Controlled Trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"B196","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1176\/appi.ajp.159.3.419","article-title":"Higher Expression of Serotonin 5-HT(2A) Receptors in the Postmortem Brains of Teenage Suicide Victims","volume":"159","author":"Pandey","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"B197","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The Pharmacology of Psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/2045125312445469","article-title":"The Drugs Don't Work? Antidepressants and the Current and Future Pharmacological Management of Depression","volume":"2","author":"Penn","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of Psilocybin on Empathy and Moral Decision-Making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF02860623","article-title":"Tabernanthe Iboga: an African Narcotic Plant of Social Importance","volume":"23","author":"Pope","year":"1969","journal-title":"Econ. Bot."},{"key":"B201","first-page":"235","article-title":"100 Years of Ibogaine: Neurochemical and Pharmacological Actions of a Putative Anti-addictive Drug","volume":"47","author":"Popik","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"B202","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1021\/acschemneuro.9b00528","article-title":"DARK Classics in Chemical Neuroscience: NBOMes","volume":"11","author":"Poulie","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1569-7339(10)70102-8","article-title":"Serotonin and Schizophrenia","volume-title":"Handbook of Behavioral Neuroscience. Handbook of the Behavioral Neurobiology of Serotonin","author":"Quednow","year":"2010"},{"key":"B204","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0014-2999(96)00690-5","article-title":"Ibogaine and Noribogaine Potentiate the Inhibition of Adenylyl Cyclase Activity by Opioid and 5-HT Receptors","volume":"316","author":"Rabin","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fnins.2014.00426","article-title":"Nicotinic Receptor Modulation to Treat Alcohol and Drug Dependence","volume":"8","author":"Rahman","year":"2015","journal-title":"Front. Neurosci."},{"key":"B206","first-page":"39","article-title":"Comorbidity between Depressive and Addictive Disorders in Adolescents: Role of Stress and HPA Activity","volume":"3","author":"Rao","year":"2010","journal-title":"U. S. Psyc"},{"key":"B207","doi-asserted-by":"publisher","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the Human Receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLOS ONE"},{"key":"B208","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and Psychedelic-Assisted Psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1021\/jo00087a037","article-title":"Abbreviated Ibogaine Congeners. Synthesis and Reactions of Tropan-3-Yl-2- and -3-indoles. Investigation of an Unusual Isomerization of 2-Substituted Indoles Using Computational and Spectroscopic Techniques","volume":"59","author":"Repke","year":"1994","journal-title":"J. Org. Chem."},{"key":"B210","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0091-3057(95)00152-m","article-title":"Attenuation of Alcohol Intake by Ibogaine in Three Strains of Alcohol-Preferring Rats","volume":"52","author":"Rezvani","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B211","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/jpet.103.049882","article-title":"Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics","volume":"306","author":"Riba","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor Interaction Profiles of Novel Psychoactive Tryptamines Compared with Classic Hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1021\/acschemneuro.0c00152","article-title":"A Single Administration of the Atypical Psychedelic Ibogaine or its Metabolite Noribogaine Induces an Antidepressant-like Effect in Rats","volume":"11","author":"Rodr\u0131 Guez","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional Breakthrough and Psychedelics: Validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. PharmacolFrontiers"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-Threatening Cancer: a Randomized Controlled Trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1590\/1516-4446-2020-0884","article-title":"The Pharmacological Interaction of Compounds in Ayahuasca: a Systematic Review","volume":"42","author":"Ruffell","year":"20201999","journal-title":"Braz J. Psychiatry"},{"key":"B218","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awq367","article-title":"The Sigma-1 Receptor Enhances Brain Plasticity and Functional Recovery after Experimental Stroke","volume":"134","author":"Ruscher","year":"2011","journal-title":"Brain"},{"key":"B219","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00213-019-05279-z","article-title":"Replication and Extension of a Model Predicting Response to Psilocybin","volume":"236","author":"Russ","year":"2019","journal-title":"Psychopharmacol. Berl."},{"key":"B220","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbr.2008.11.036","article-title":"Sigma-1 Receptor Knockout Mice Display a Depressive-like Phenotype","volume":"198","author":"Sabino","year":"2009","journal-title":"Behav. Brain Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF00441948","article-title":"Hallucinogenic Drug Interactions at Human Brain 5-HT2 Receptors: Implications for Treating LSD-Induced Hallucinogenesis","volume":"98","author":"Sadzot","year":"1989","journal-title":"Psychopharmacol. Berl."},{"key":"B222","first-page":"925","article-title":"Accumulation of N,N-dimethyltryptamine in Rat Brain Cortical Slices","volume":"14","author":"Sangiah","year":"1979","journal-title":"Biol. Psychiatry"},{"key":"B223","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jep.2007.04.012","article-title":"Effects of Ayahuasca on Psychometric Measures of Anxiety, Panic-like and Hopelessness in Santo Daime Members","volume":"112","author":"Santos","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"niaa024","DOI":"10.1093\/nc\/niaa024","article-title":"Neural Network Models for DMT-Induced Visual Hallucinations","volume":"2020","author":"Schartner","year":"2020","journal-title":"Neurosci. Conscious"},{"key":"B225","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating Drug Dependence with the Aid of Ibogaine: a Retrospective Study","volume":"28","author":"Schenberg","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/00008877-199312000-00011","article-title":"Blockade of the Acquisition of Cocaine Self-Administration by the NMDA Antagonist MK-801 (Dizocilpine)","volume":"4","author":"Schenk","year":"1993","journal-title":"Behav. Pharmacol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1749-6632.1957.tb40765.x","article-title":"Neuropharmacological Studies on Ibogaine, an Indole Alkaloid with Central-Stimulant Properties","volume":"66","author":"Schneider","year":"1957","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B228","volume-title":"Plants of the Gods: Origins of Hallucinogenic Use","author":"Schultes","year":"1980"},{"key":"B229","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/0024-3205(92)90344-o","article-title":"Ibogaine Antagonizes Cocaine-Induced Locomotor Stimulation in Mice","volume":"50","author":"Sershen","year":"1992","journal-title":"Life Sci."},{"key":"B231","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0140-6736(12)60600-x","article-title":"Shaping the Renaissance of Psychedelic Research","volume":"380","author":"Sessa","year":"2012","journal-title":"Lancet"},{"key":"B259","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780199252923.001.0001","author":"Shanon","year":"2002","journal-title":"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience"},{"key":"B232","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of Nitric Oxide in Inflammatory Diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.neuroscience.2008.11.036","article-title":"Elevated 5-HT 2A Receptors in Postmortem Prefrontal Cortex in Major Depression Is Associated with Reduced Activity of Protein Kinase A","volume":"158","author":"Shelton","year":"2009","journal-title":"Neuroscience"},{"key":"B234","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/medicines6040106","article-title":"Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review","volume":"6","author":"Sim\u00e3o","year":"2019","journal-title":"Medicines"},{"key":"B235","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/jat\/29.8.838","article-title":"A Fatal Intoxication Following the Ingestion of 5-Methoxy-N,n-Dimethyltryptamine in an Ayahuasca Preparation","volume":"29","author":"Sklerov","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s0091-3057(98)00110-5","article-title":"Agonist Properties of N,N-dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors","volume":"61","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B237","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF02805969","article-title":"Pharmacological Screen for Activities of 12-hydroxyibogamine: a Primary Metabolite of the Indole Alkaloid Ibogaine","volume":"127","author":"Staley","year":"1996","journal-title":"Psychopharmacol. Berl."},{"key":"B238","volume-title":"Psilocybin Mushrooms of the World: An Identification Guide","author":"Stamets","year":"1996"},{"key":"B239","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose-response Study of N,N-dimethyltryptamine in Humans. I. Neuroendocrine, Autonomic, and Cardiovascular Effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, Subacute and Long-Term Subjective Effects of Psilocybin in Healthy Humans: a Pooled Analysis of Experimental Studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF02245936","article-title":"Receptor Binding Profile Suggests Multiple Mechanisms of Action Are Responsible for Ibogaine's Putative Anti-addictive Activity","volume":"118","author":"Sweetnam","year":"1995","journal-title":"Psychopharmacol. Berl."},{"key":"B242","doi-asserted-by":"publisher","first-page":"e106533","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N,N-dimethyltryptamine and 5-Methoxy-N,n-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PloS One"},{"key":"B243","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.neuropharm.2021.108612","article-title":"N,N-Dimethyltryptamine Attenuates Spreading Depolarization and Restrains Neurodegeneration by Sigma-1 Receptor Activation in the Ischemic Rat Brain","volume":"192","author":"Szab\u00f3","year":"2021","journal-title":"Neuropharmacology"},{"key":"B244","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fpsyt.2017.00080","article-title":"The Safety of Ingested Caffeine: A Comprehensive Review","volume":"8","author":"Temple","year":"2017","journal-title":"Front. Psychiatry"},{"key":"B245","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","article-title":"Ayahuasca-assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada","volume":"6","author":"Thomas","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"B246","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","article-title":"Psilocybin - Summary of Knowledge and New Perspectives","volume":"24","author":"Tyl\u0161","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(95)11662-g","article-title":"N-methyl-D-aspartic Acid-Receptor Antagonists Block Morphine-Induced Conditioned Place Preference in Rats","volume":"193","author":"Tzschentke","year":"1995","journal-title":"Neurosci. Lett."},{"key":"B248","unstructured":"Low Doses of Psychedelic Drug Erases Conditioned Fear in Mice2013"},{"key":"B249","unstructured":"Research2021"},{"key":"B250","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.yrtph.2011.01.006","article-title":"Harm Potential of Magic Mushroom Use: A Review","volume":"59","author":"van Amsterdam","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1254\/jphs.10191fp","article-title":"Pharmacological Interaction with the Sigma1 (\u03c31)-Receptor in the Acute Behavioral Effects of Antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"B252","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"B253","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients' Accounts of Increased \"Connectedness\" and \"Acceptance\" after Psilocybin for Treatment-Resistant Depression","volume":"57","author":"Watts","year":"2017","journal-title":"J. Humanist. Psychol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/s0006-8993(98)00527-7","article-title":"Acute Iboga Alkaloid Effects on Extracellular Serotonin (5-HT) Levels in Nucleus Accumbens and Striatum in Rats","volume":"800","author":"Wei","year":"1998","journal-title":"Brain Res."},{"key":"B255","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1566524015666150330142807","article-title":"Specific Roles of NMDA Receptor Subunits in Mental Disorders","volume":"15","author":"Yamamoto","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"B256","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000136294","article-title":"Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids","volume":"7","author":"Zetler","year":"1972","journal-title":"Pharmacology"},{"key":"B257","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The Role of Serotonin 5-HT2A Receptors in Memory and Cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0893-133X(99)00003-2","article-title":"Noribogaine Generalization to the Ibogaine Stimulus: Correlation with Noribogaine Concentration in Rat Brain","volume":"21","author":"Zubaran","year":"1999","journal-title":"Neuropsychopharmacology"}],"updated-by":[{"DOI":"10.3389\/fphar.2023.1184726","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.927984\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T20:48:50Z","timestamp":1700772530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.927984\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":261,"alternative-id":["10.3389\/fphar.2022.927984"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.927984","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2023.1184726","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"927984"}}